Advertisement

Topics

Taro Pharmaceutical Ind. Company Profile

14:52 EDT 23rd September 2017 | BioPortfolio

Taro markets a broad range of prescription and over-the-counter products in the United States. We are a leading manufacturer and supplier of topical dermatological products and also have a growing line of solid dosage form products used mainly in cardiology and neurology.


News Articles [508 Associated News Articles listed on BioPortfolio]

Taro to Announce First Quarter Results on August 8, 2017

Taro Pharmaceutical Industries Ltd. (NYSE:TARO) announced today that it plans to release its financial results for the quarter ended June 30, 2017, after the close of market on Tu...

Taro Announces Joining of CEO

Taro Pharmaceutical Industries Ltd. (NYSE:TARO) (“Taro” or the “Company”) announced today that Mr. Uday Baldota has joined the Company as its Chief Executive Officer (“C...

Taro Annual Report on Form 20-F Available for Fiscal Year Ended March 31, 2017

Taro Pharmaceutical Industries Ltd. (NYSE:TARO, “Taro”) announced that its Annual Report on Form 20-F for the fiscal year ended March 31, 2017, filed with the Securities and E...

Taro Pharmaceutical Industries Ltd. (TARO) Issues Quarterly Earnings Results

Taro Pharmaceutical Industries Ltd. issued its earnings results on Monday. The company reported $2.05 EPS for the quarter.

Taro Pharmaceutical Industries' (TARO) Interim CEO Abhay Gandhi on Q4 2017 Results - Earnings Call Transcript

Taro to Announce Results for Year Ended March 31, 2017 on May 22, 2017

Earnings Call to Discuss Results to be Conducted Tuesday, May 23 at 8:00 am EDT Taro Pharmaceutical Industries Ltd. (NYSE:TARO) announced today that it plans to release...

Taro Pharmaceutical: A Gem In Trouble

The Long Case For Taro Pharmaceutical

Drugs and Medications [378 Associated Drugs and Medications listed on BioPortfolio]

Cetirizine hydrochloride [Taro Pharmaceutical Industries, Ltd.]

Children's Cetirizine Hydrochloride Oral Solution

Clotrimazole [Taro Pharmaceuticals U.S.A., Inc.]

Clotrimazole Topical Solution USP,1%

Clotrimazole [Taro Pharmaceuticals, Inc.]

Clotrimazole Topical Solution USP,1%

Clotrimazole [Taro Pharmaceuticals U.S.A., Inc.]

Clotrimazole Cream USP,1% Antifungal Cream

Clotrimazole [Taro Pharmaceuticals, Inc.]

Clotrimazole Cream USP,1% Antifungal Cream

PubMed Articles [486 Associated PubMed Articles listed on BioPortfolio]

Oxalate Content of Taro Leaves Grown in Central Vietnam.

Leaves were harvested from four different cultivars of Colocasia esculenta and three cultivars of Alocasia odora that were growing on nine different farms in central Vietnam. The total, soluble and in...

Anti-inflammatory lignanamides and monoindoles from Alocasia macrorrhiza.

Five new lignanamides (1-5), and one new monoindole alkaloid (6), along with eight known compounds (7-14) were isolated and identified from the rhizomes of Alocasia macrorrhiza (giant taro). All purif...

Critical review of surface-enhanced Raman spectroscopy applications in the pharmaceutical field.

Surface-enhanced Raman spectroscopy (SERS) is a sensitive analytical tool used in the pharmaceutical field in recent years. SERS keeps all the advantages of classical Raman spectroscopy while being is...

Adventures in the Environmental World and Environmental Microbiology Sampling of Air for Pharmaceutical Sterile Compounding.

Chapter issued by the United States Pharmacopeial Convention, Inc. is the standard for sterile compounding. It is designed to reduce the number of patient infections due to contaminated pharmaceutica...

Can pharmaceutical co-crystals provide an opportunity to modify the biological properties of drugs?

Poorly soluble and/or permeable molecules jeopardize the discovery and development of innovative medicines. Pharmaceutical co-crystals, formed by an active pharmaceutical substance (API) and a co-crys...

Clinical Trials [269 Associated Clinical Trials listed on BioPortfolio]

A Therapeutic Equivalence Study of Two Imiquimod Cream 5% Treatments for Patients With Actinic Keratosis

The primary objectives are to establish the therapeutic equivalence of imiquimod cream 5%, manufactured by Taro Pharmaceuticals Inc. and Aldara (imiquimod) cream, manufactured by 3M, and t...

Clinical Equivalence of Two Butenafine Hydrochloride 1% Creams in Patients With Interdigital Tinea Pedis

To demonstrate comparable safety and efficacy of Taro Pharmaceuticals Inc. butenafine hydrochloride cream 1% (test product) and Lotrimin Ultra® cream (reference listed drug) in the treatm...

Pharmaceutical Care for Asthma Control Improvement (PHARMACI)-Study

The objective of this study is to evaluate the therapeutic effectiveness and cost-effectivity of pharmaceutical care for asthma patients.

Pharmaceutical Care for Diabetes Type 2 Patients: a Randomised Controlled Trial

The objective of this study is to evaluate the therapeutic effectiveness and cost-effectivity of pharmaceutical care for diabetes type 2 patients. Patients will be randomly allocated to th...

Improving Compliance Among Elderly Polypharmacy Users Through Community Pharmacy Based Pharmaceutical Care Program

The aim of the project is to evaluate effectiveness of a multidimensional pharmaceutical care plan in improving compliance among elderly polypharmacy users at community pharmacy settings. ...

Companies [1001 Associated Companies listed on BioPortfolio]

Taro Pharmaceutical Ind.

Taro markets a broad range of prescription and over-the-counter products in the United States. We are a leading manufacturer and supplier of topical dermatological products and also have a growing li...

Taro Pharmaceuticals U.S.A., Inc.

Taro entered the U.S. market in 1988, after establishing its Canadian subsidiary in 1984 and receiving approval of its first topical product in the United States.The U.S. has become Taro’s largest m...

 Taro Pharmaceutical Industries Ltd.

Taro Pharmaceutical Industries Ltd.

Taro Pharmaceutical Industries develops, manufactures, and markets high-quality generic and branded pharmaceuticals, both prescription and over-the-counter, used by patients in countries around the wo...

Sun Pharmaceuticals, Inc., Taro Pharmaceutical Industries Ltd.

Established in 1983, listed since 1994 and headquartered in India, Sun Pharmaceutical Industries Ltd. (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE: 524715) is an international, integr...

More Information about "Taro Pharmaceutical Ind." on BioPortfolio

We have published hundreds of Taro Pharmaceutical Ind. news stories on BioPortfolio along with dozens of Taro Pharmaceutical Ind. Clinical Trials and PubMed Articles about Taro Pharmaceutical Ind. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Taro Pharmaceutical Ind. Companies in our database. You can also find out about relevant Taro Pharmaceutical Ind. Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topics

Cardiology
Cardiology is a specialty of internal medicine.  Cardiac electrophysiology : Study of the electrical properties and conduction diseases of the heart. Echocardiography : The use of ultrasound to study the mechanical function/physics of the h...

Neurology - Central Nervous System (CNS)
Alzheimer's Disease Anesthesia Anxiety Disorders Autism Bipolar Disorders Dementia Epilepsy Multiple Sclerosis (MS) Neurology Pain Parkinson's Disease Sleep Disorders Neurology is the branch of me...


Corporate Database Quicklinks



Searches Linking to this Company Record